Patheon‘s solid dose manufacturing facility in Manati, Puerto Rico received regulatory approval from the EMEA following the completion of a successful inspection in May by the Medical Products Agency of Sweden. The inspection of the facility marks 19 successful regulatory inspections at nine manufacturing sites for the company in 2009, including eight FDA inspections and two European inspections.

“Patheon’s track record of regulatory compliance underscores our commitment to quality and reliability for our customers,” said Terry Novak, President, Patheon North America. “The approval of our Manati facility allows us to ship solid dosage product into Europe from Puerto Rico, which provides additional benefit and flexibility for our clients.”

Sign up today for Contracting & Outsourcing 2009!